Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma - a randomized multicenter study. The European study group of erythropoietin (Epoetin Beta) treatment in multiple myeloma and non-Hodgkin's lymphoma

By Fossa A.   Brandhorst D.   Myklebust J.H.   Seeber S.   Nowrousian M.R.  

Experimental Hematology, Vol. 27, Iss. 11, 1999-11 ,pp. : 1621-1626

Elsevier

Access to resources Recommend Favorite

Erythropoietin response is inadequate in cancer patients receiving chemotherapy

By Lee Sang   Kwon Jung   Jung Chul  

International Journal of Hematology, Vol. 74, Iss. 4, 2001-12 ,pp. : 416-420

Springer Publishing Company

Access to resources Recommend Favorite

Differential diagnosis of microcytic anemia: the role of microcytic and hypochromic erythrocytes

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 3, 2015-06 ,pp. : 334-340

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of WT1 gene in multiple myeloma patients at diagnosis: is WT1 gene expression a useful marker in multiple myeloma?

By Saatci Cetin   Caglayan A. Okay   Kocyigit Ismail   Akalin Hilal   Kaynar Leyla G.   Altuntas Fevzi   Eser Bulent   Demir Muzaffer   Cetin Mustafa   Ozkul Yusuf  

Hematology, Vol. 15, Iss. 1, 2010-02 ,pp. : 39-42

Maney Publishing

Access to resources Recommend Favorite

Restricted TCR V α gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis

By Zang Y.  

International Immunology, Vol. 10, Iss. 7, 1998-07 ,pp. : 991-998

Oxford University Press

Access to resources Recommend Favorite